Screening for sleep apnoea risk in testosterone-treated transgender men

Bára Šnobrová, Kristina Burdová, Vladimír Weiss, Karel Šonka, Petr Weiss · 2023

Read Screening for sleep apnoea risk in testosterone-treated transgender men by Bára Šnobrová, Kristina Burdová, Vladimír Weiss, Karel Šonka, Petr Weiss (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10729444.txt.

Description

Bara Snobrova and co-authors screen for sleep apnoea risk in transgender men treated with testosterone. Obstructive sleep apnoea is more common in men than in women. Higher testosterone levels have been linked to greater apnoea risk in past studies.

The team followed adults in female-to-male transition on testosterone treatment. Each person answered a standard sleep questionnaire before treatment began. They answered again after at least one year on treatment. More people reported snoring at follow-up, while fewer reported daytime tiredness. The overall share at high apnoea risk did not change much. Snoring reports alone rose, the authors note. The study informs sleep checks during hormone care.

Catalog record

CREATORBára Šnobrová, Kristina Burdová, Vladimír Weiss, Karel Šonka, Petr Weiss
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE11 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10729444

Browse the full library · About the Tower of Babel